文献速递介入外周血管腹部DSA

使用新型成像技术降低经颈静脉肝内门体分流术植入过程中的辐射剂量

Radiation dose reduction during transjugular intrahepatic portosystemic shunt implantation using a new imaging technology.
PubMed 文献 · Eur J Radiol · 2016-11-24

该回顾性单中心研究将108例年龄和BMI匹配的TIPS植入患者按技术升级前后分为两组,各54例,比较患者辐射剂量。新技术使平均DAP降低57%(402.8 vs 173.3 Gycm2,p<0.001),平均AK降低58%(1.7 vs 0.7 Gy,p<0.001),透视时间和对比剂用量无显著差异,DSA图像质量不劣于前代技术(2.66 vs 2.77,p=0.56)。

要点

  • 新技术使TIPS植入患者平均DAP降低57%、平均AK降低58%。
  • 透视时间(26.4 vs 27.8 min,p=0.45)和对比剂用量(109.4 vs 114.9 ml,p=0.62)无显著差异。
  • DSA图像质量不劣于前代技术(2.66 vs 2.77,p=0.56)。

核心结论

  • 在本研究中,新型成像技术使TIPS植入患者的辐射剂量减半,同时保持足够的图像质量,且未显著增加辐射时间或对比剂消耗。

研究设计与样本

  • 回顾性单中心研究,纳入年龄和BMI匹配的108例接受TIPS植入的患者,技术升级前54例、升级后54例;采用双尾t检验比较均值,由两名盲法独立阅片者使用四级Likert量表评估DSA图像质量,采用Wilcoxon检验。

诊断标准与关键数值

  • 新技术组平均DAP为173.3 Gycm2,前代技术组为402.8 Gycm2,新技术降低57%(p<0.001)。
  • 新技术组平均AK为0.7 Gy,前代技术组为1.7 Gy,新技术降低58%(p<0.001)。
  • 新技术组透视时间为27.8 min,前代技术组为26.4 min(p=0.45),两组无显著差异。
  • 新技术组对比剂用量为114.9 ml,前代技术组为109.4 ml(p=0.62),两组无显著差异。
  • 新技术组DSA图像质量评分为2.66,前代技术组为2.77(p=0.56),新技术不劣于前代技术。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To compare patient radiation dose in patients undergoing transjugular intrahepatic portosystemic shunt (TIPS) implantation before and after an imaging-processing technology upgrade.

METHODS: In our retrospective single-center-study, cumulative air kerma (AK), cumulative dose area product (DAP), total fluoroscopy time and contrast agent were collected from an age- and BMI-matched collective of 108 patients undergoing TIPS implantation. 54 procedures were performed before and 54 after the technology upgrade. Mean values were calculated and compared using two-tailed t-tests. Two blinded, independent readers assessed DSA image quality using a four-rank likert scale and the Wilcoxcon test.

RESULTS: The new technology demonstrated a significant reduction of 57% of mean DAP (402.8 vs. 173.3Gycm2, p<0.001) and a significant reduction of 58% of mean AK (1.7 vs. 0.7Gy, p<0.001) compared to the precursor technology. Time of fluoroscopy (26.4 vs. 27.8min, p=0.45) and amount of contrast agent (109.4 vs. 114.9ml, p=0.62) did not differ significantly between the two groups. The DSA image quality of the new technology was not inferior (2.66 vs. 2.77, p=0.56).

CONCLUSIONS: In our study the new imaging technology halved radiation dose in patients undergoing TIPS maintaining sufficient image quality without a significant increase in radiation time or contrast consumption.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Spink C, Avanesov M, Schmidt T, et al. Radiation dose reduction during transjugular intrahepatic portosystemic shunt implantation using a new imaging technology. Eur J Radiol. 2016. PMID: 28027761. doi:10.1016/j.ejrad.2016.11.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。